Adrenocorticotropic hormone independent macronodular adrenal hyperplasia due to aberrant receptor expression: is medical treatment always an option?

Abstract

OBJECTIVE:

To investigate the efficacy of medical treatment as an alternative option to bilateral adrenalectomy in patients with cortisol excess due to adrenocorticotropic hormone (ACTH) independent macronodular adrenal hyperplasia (AIMAH).

METHODS:

We focused on the efficacy of somatostatin analogues in a patient with food-dependent AIMAH and of leuprolide acetate in a patient with AIMAH due to aberrant LH/hCG receptor expression.

RESULTS:

Two female patients with bilateral macronodular adrenal hyperplasia and cortisol excess were evaluated for the presence of aberrant cortisol responses. One patient demonstrated an aberrant response to mixed meal and the other, a menopausal female, to luteinizing hormone-releasing hormone (LHRH) and human chorionic gonadotropin (hCG) administration. In the first patient, subcutaneous octreotide was administered prior to mixed meal and completely abolished food-induced cortisol secretion. Thus, the patient was treated with the long-acting somatostatin analogue octreotide long-acting release (LAR) for 3 months. There was no control of cortisol excess upon reevaluation and acute subcutaneous octreotide administration prior to meal was no longer effective in blocking food-induced cortisol secretion. The second patient successfully responded to leuprolide acetate and, for 40 months, her cortisol excess remains in long-term control.

CONCLUSIONS:

A luteinizing hormone/human chorionic gonadotropin (LH/hCG) responsive patient with AIMAH sustained long-term control of cortisol excess on leuprolide acetate. In contrast, in a meal-responsive patient with apparent gastric inhibitory polypeptide (GIP) dependent AIMAH, did not achieve remission under somatostatin analogues.

• Authors: Olga Karapanou, Barbara Vlassopoulou, Marinella Tzanela, Theodora Stratigou, Vassilios Tsatlidis, Sofia Tsirona, Stylianos Tsagarakis
• Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (Endocr Pract) 2013 May-Jun Vol. 19 Issue 3 Pg. e77-82 ISSN: 1934-2403 [Electronic] United States
• PMID: 23425648 (Publication Type: Case Reports, Journal Article)

Chemical References

• Chorionic Gonadotropin
• Luteinizing Hormone
• Octreotide

Topics

• Adult
• Chorionic Gonadotropin (therapeutic use)
• Cushing Syndrome (drug therapy, metabolism)
• Female
• Humans
• Luteinizing Hormone (therapeutic use)
• Middle Aged
• Octreotide (therapeutic use)